Search results
Aug 5, 2022 · This article updates and replaces the 2004 American Academy of Pediatrics (AAP) clinical practice guideline for the management and prevention of hyperbilirubinemia in the newborn infant ≥35 weeks’ gestation. 3 This clinical practice guideline, like the previous one, addresses issues of prevention, risk assessment, monitoring, and treatment.
Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation. Features. Neurotoxicity risk factors absent, present, or both. Plot multiple time points to assess trends.
Informed guidance on hyperbilirubinemia management, including preventive treatment thresholds, is critical to safely minimize neurodevelopmental risk. AAP Recommendations. In August 2022, the Academy released updated clinical guidance on the prevention and treatment of hyperbilirubinemia in newborns greater than 35 weeks of gestational age.
Sep 1, 2022 · Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Sep 1;150 (3):e2022058859. doi: 10.1542/peds.2022-058859. Authors.
Nov 4, 2022 · The highly anticipated update to the American Academy of Pediatrics (AAP) Clinical Practice Guideline for management of hyperbilirubinemia in newborns ≥35 weeks gestation was published in August 2022. 1 The revised guideline and accompanying technical report 2 build on the prior recommendations with a decade and a half of new research.
Sep 6, 2022 · 2022 Updated clinical practice guidelines on the management of hyperbilirubinemia in newborn infants of ≥35 weeks’ gestation from the American Academy of Pediatrics, published in the journal...
AAP 2022 Hyperbilirubinemia Management Guidelines. Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation.
Jan 10, 2024 · To help with implementation of the 2022 AAP guideline on the management of hyperbilirubinemia, members of the authoring group with input from other members of the AAP have put together this FAQ sheet.
Aug 5, 2022 · To update the evidence base necessary to develop the 2022 American Academy of Pediatrics clinical practice guideline for management of hyperbilirubinemia in the newborn infant ≥35 weeks’...
Dec 1, 2023 · Given the prevalence of jaundice in newborns, and the consequences of untreated hyperbilirubinemia, the long-awaited revised clinical practice guidelines for hyperbilirubinemia were finally...
